Pharma Articles
Articles on key issues related to the pharma industry from the heads of leading pharmaceutical companies and pharma industry experts across the globe. The pharma industry articles' section focuses on current and emerging issues in areas such as Strategic developments in the pharma industry, pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical manufacturing, biopharmaceuticals, and information technology.
The Role of Technology in Continued Process Verification 4.0
The Quality Leaders in the Pharmaceutical Industry would feel no less than wearing a super hero cape if they had a mechanism to detect and resolve product quality issues before they even arise where they could monitor the processes in realtime and improve them where compliance is integrated into th...
Advanced Drug Delivery Systems for Chronic Liver Disease Management
In the past two decades chronic liver disease CLD has become increasingly prevalent across various age groups Although the elderly were considered to be at high risk earlier the increasing rates of obesity diabetes hepatitis and excessive alcohol consumption have contributed to increasing CLD occurr...
Boosting NICU Safety
How pharmacist interventions reduce drug-related problems in newborns
Neonate is a child under days of age In the Neonatal Intensive Care Unit NICU neonates are particularly vulnerable to drugrelated problems DRPs due to several factors including
AI Cures
Repurposing Old Drugs for New Threats
Ever wondered why the specter of infectious diseases like COVID still haunts us despite decades of medical advancements The answer lies in the escalating threat of antimicrobial resistance
The Regulatory Landscape for Nutraceuticals
Striking a balance between innovation and safety
With time nutraceuticals are becoming increasingly demanding in the global as well as Indian markets According to Grand View Research the India nutraceuticals market size is projected to grow at a CAGR of from to
Harnessing Artificial Intelligence
The new frontier in pharmaceutical innovation
The incorporation of Artificial Intelligence AI in the discovery and development of drugs represents a significant step towards transforming drug delivery systems
Multi-Target Directed Ligands and Lipidomics Approach for Glioblastoma Drug Discovery
The traditional pharmaceutical approach of designing a diseasesymptomspecific drug has historically proven effective However this methodology often falls short due to the complex and often multifactorial etiology of diseases
Government Investment in AI Capabilities will Cement Singapore’s Position as a Premier Clinical Trial Location
As Asia establishes itself as the global hub for clinical trials Singapore is bolstering its position as the preferred location for these trials to take place The countrys strong RD capabilities talent pool world class healthcare infrastructure and robust regulatory
Revolutionising Drug Discovery and Development with Artificial Intelligence
As the global pharma industry continues its shift towards precision medicine in the quest for targeting undruggable targets research and development activities have experienced a tremendous surge
Pharma Firms Must Come Together, Ensure Access to Antibiotics in Poor Countries to Take on Superbugs
In an era marked by remarkable medical advancements a disquieting paradox is staring at us While many parts of the world face a growing threat of antimicrobial resistance owing to overuse of antibiotics several low and middle income countries
Viksit Bharat@ 2047 envisioned the Indian Pharma Industry
India as a potential hub for pharmaceutical investors to meet the global crisis of drugs
The Indian Pharmaceuticals industry has emerged globally as one of the fastest growing industries The pharmaceutical industry in India is expected to reach Bn by and Bn by The pharmaceutical industry
The Transformative Impact of AI on Regulatory Affairs
Regulatory affairs in the pharmaceutical industry encompass a broad and complex field that is essential for the development approval and postmarketing surveillance of pharmaceutical products This domain acts as the critical nexus between pharmaceutical companies
APAC’s Biopharma Providers’ Role in Pioneering a Healthcare Revolution
Asias healthcare landscape is undergoing a transformative journey grappling with profound challenges in changing demographics persistent health inequities and the rising burden of increased disease prevalence
There’s Finally Hope to Alleviate the Burden of Chronic Diseases
As societies in Asia grow older chronic diseases are becoming more and more prevalent They place serious strain not only on patients but also on caregivers and the healthcare system
The Potential of Cell Free Chromatin Inhibition in Cancer
A comment
Since seminal work by Dr Mitra from Tata Medical Centre has been done on Cellfree chromatin particles that are released upon cell death When cancer cells die the skeletons of mutated cell free
